Analysts Conflicted on These Real Estate Names: Agree Realty (ADC) and Choice Properties Real Estate Investment (OtherPPRQF)
Analysts have been eager to weigh in on the Real Estate sector with new ratings on Agree Realty (ADC – Research Report) and Choice Properties Real Estate Investment (PPRQF – Research Report).
Stay Ahead of the Market:
Discover outperforming stocks and invest smarter with Top Smart Score Stocks.
Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener.
Agree Realty (ADC)
RBC Capital analyst Brad Heffern maintained a Buy rating on Agree Realty on April 24 and set a price target of $79.00. The company's shares closed last Friday at $75.67, close to its 52-week high of $78.39.
According to TipRanks.com, Heffern is a 5-star analyst with an average return of 7.2% and a 45.7% success rate. Heffern covers the NA sector, focusing on stocks such as National Retail Properties, Mid-America Apartment, and Independence Realty.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Agree Realty with a $79.14 average price target, a 3.5% upside from current levels. In a report issued on April 15, Morgan Stanley also maintained a Buy rating on the stock with a $75.00 price target.
In a report issued on April 24, Pammi Bir from RBC Capital maintained a Hold rating on Choice Properties Real Estate Investment, with a price target of C$15.00. The company's shares closed last Wednesday at $10.41.
According to TipRanks.com, Bir is a 4-star analyst with an average return of 7.6% and a 53.6% success rate. Bir covers the NA sector, focusing on stocks such as Allied Properties Real Estate Investment Trust, NorthWest Healthcare Properties REIT, and Dream Office Real Estate Investment.
Choice Properties Real Estate Investment has an analyst consensus of Moderate Buy, with a price target consensus of $11.24, representing a 8.0% upside. In a report issued on April 23, Raymond James also downgraded the stock to Hold with a C$16.00 price target.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
6 hours ago
- Business Insider
Analysts Offer Insights on Consumer Cyclical Companies: Trigano SA (OtherTGNOF) and Williams-Sonoma (WSM)
Companies in the Consumer Cyclical sector have received a lot of coverage today as analysts weigh in on Trigano SA (TGNOF – Research Report) and Williams-Sonoma (WSM – Research Report). Confident Investing Starts Here: Trigano SA (TGNOF) Kepler Capital analyst Alessandro Cuglietta maintained a Buy rating on Trigano SA on June 16 and set a price target of EUR178.00. The company's shares closed last Friday at $143.62. Cuglietta has an average return of 11.3% when recommending Trigano SA. According to Cuglietta is ranked #9309 out of 9621 analysts. Trigano SA has an analyst consensus of Strong Buy, with a price target consensus of $194.35. Williams-Sonoma (WSM) Evercore ISI analyst Oliver Wintermantel maintained a Hold rating on Williams-Sonoma yesterday and set a price target of $170.00. The company's shares closed last Tuesday at $156.93. According to Wintermantel is a 4-star analyst with an average return of 14.2% and a 71.8% success rate. Wintermantel covers the NA sector, focusing on stocks such as Petco Health and Wellness Company, Tractor Supply, and Wayfair. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Williams-Sonoma with a $181.06 average price target, which is a 15.4% upside from current levels. In a report issued on June 16, Barclays also maintained a Hold rating on the stock with a $166.00 price target.
Business Insider
6 hours ago
- Business Insider
Analysts Offer Insights on Healthcare Companies: Kuros Biosciences (OtherCSBTF), CSL (OtherCMXHF) and Roche Holding AG (OtherRHHVF)
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Kuros Biosciences (CSBTF – Research Report), CSL (CMXHF – Research Report) and Roche Holding AG (RHHVF – Research Report) with bullish sentiments. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Kuros Biosciences (CSBTF) Kepler Capital analyst Christophe dombu maintained a Buy rating on Kuros Biosciences on June 16 and set a price target of CHF32.50. The company's shares closed last Wednesday at $33.22, close to its 52-week high of $36.10. According to dombu is ranked #8486 out of 9621 analysts. The the analyst consensus on Kuros Biosciences is currently a Hold rating. CSL (CMXHF) Morgan Stanley analyst David Bailey maintained a Buy rating on CSL today and set a price target of A$303.00. The company's shares closed last Tuesday at $148.56. According to Bailey is a 4-star analyst with an average return of 16.4% and a 48.1% success rate. Bailey covers the Healthcare sector, focusing on stocks such as Fisher & Paykel Healthcare Corporation Limited, Ramsay Health Care, and Cochlear. CSL has an analyst consensus of Strong Buy, with a price target consensus of $203.87, implying a 37.2% upside from current levels. In a report released yesterday, Jarden also maintained a Buy rating on the stock with a A$317.61 price target. Roche Holding AG (RHHVF) Kepler Capital analyst David Evans maintained a Buy rating on Roche Holding AG on June 16 and set a price target of CHF315.00. The company's shares closed last Tuesday at $321.13. According to Evans is ranked #4919 out of 9621 analysts. The word on The Street in general, suggests a Hold analyst consensus rating for Roche Holding AG with a $352.85 average price target, implying an 8.3% upside from current levels. In a report issued on June 16, UBS also maintained a Buy rating on the stock with a CHF314.00 price target.
Business Insider
6 hours ago
- Business Insider
Analysts Offer Insights on Materials Companies: Wacker Chemie AG (OtherWKCMF) and Lynas Rare Earths (OtherLYSCF)
There's a lot to be optimistic about in the Materials sector as 2 analysts just weighed in on Wacker Chemie AG (WKCMF – Research Report) and Lynas Rare Earths (LYSCF – Research Report) with bullish sentiments. Confident Investing Starts Here: Wacker Chemie AG (WKCMF) In a report issued on June 16, Christian Faitz from Kepler Capital maintained a Buy rating on Wacker Chemie AG, with a price target of EUR104.00. The company's shares closed last Monday at $73.00, close to its 52-week low of $63.50. According to Faitz is ranked #915 out of 9621 analysts. Currently, the analyst consensus on Wacker Chemie AG is a Strong Buy with an average price target of $98.34, implying a 34.7% upside from current levels. In a report issued on June 2, Deutsche Bank also maintained a Buy rating on the stock with a EUR74.00 price target. Lynas Rare Earths (LYSCF) UBS analyst Dim Ariyasinghe maintained a Buy rating on Lynas Rare Earths today and set a price target of A$10.40. The company's shares closed last Tuesday at $6.17. According to Ariyasinghe is a 3-star analyst with an average return of 5.3% and a 58.1% success rate. Ariyasinghe covers the Basic Materials sector, focusing on stocks such as Iluka Resources Limited, Syrah Resources, and Boss Energy. Lynas Rare Earths has an analyst consensus of Hold, with a price target consensus of $5.20, representing a -16.1% downside. In a report issued on June 5, Ord Minnett also upgraded the stock to Buy with a A$8.70 price target.
